Skip to main content

Table 1 Characteristics of the study participants—DPP4I study, Anuradhapura 2017

From: Comparison of biochemical parameters among DPP4 inhibitor users and other oral hypoglycaemic drug users: a cross-sectional study from Anuradhapura, Sri Lanka

Items

OOH group (n = 126)

DPP4I group (n = 63)

p value

Demography

 Median age and IQR (years)

53.5 (47–59)

54 (48–60)

0.968*

 Median duration of T2DM and IQR (months)

66 (24–120)

72 (36–120)

0.204*

Co-morbidities

 Dyslipidaemia

37.3% (47/126)

55.6% (35/63)

0.017^

 Hypertension

44.4% (56/126)

60.3% (38/63)

0.040^

 Ischaemic heart disease

9.5% (12/126)

12.7% (8/63)

0.504^

 Hypothyroidism

3.2% (4/126)

1.6% (1/63)

0.086#

 Hyperthyroidism

1.6% (2/126)

3.2% (2/63)

0.815#

 Asthma

1.6% (2/126)

00

0.887#

 Osteoarthritis

0.8% (1/126)

00

0.999#

Anthropometric measurements and blood pressure

 Median BMI and IQR (kgm−2)

25.3 (23–28)

26.8 (24–30)

0.008*

 Median waist circumference and IQR (cm)

92.5 (88–99)

97 (92–102)

0.001*

 Median systolic blood pressure and IQR (mmHg)

138.5 (125–156)

141 (129–151)

0.749*

 Median diastolic blood pressure and IQR (mmHg)

84 (76–90)

84 (79–90)

0.542*

  1. BMI body mass index, DPP4I dipeptidyl peptidase 4 inhibitors, IQR interquartile range, OOH other oral hypoglycaemics, T2DM type 2 diabetes mellitus
  2. *Mann-Whitney U test was performed
  3. ^Chi-square test was performed
  4. #Fisher exact was performed